Fitzclarence Harper, MD
Pain Medicine · Stockbridge, GANPI 1962433508
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Elliquence, LLC at 42.2% of the total. 2025 is the largest year on record at $3,451, more than ten times the $323 reported in 2019.
Across 96 payments — averaging $73.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elliquence, LLC$3K
- Medtronic$1K
- Curonix LLC$986
- Abbott$377
- Collegium Pharmaceutical, Inc.$295
- Electronic Waveform Lab, Inc.$228
- plus $944 from 19 others
What the payments were for
- Consulting fees$3,00042%
- Travel & lodging$1,14516%
- Food & beverage$2,76639%
- Education$1913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elliquence, LLC | 1 | $3,000 |
| Medtronic | 15 | $1,273 |
| Curonix LLC | 12 | $986 |
| Abbott | 18 | $377 |
| Collegium Pharmaceutical, Inc. | 19 | $295 |
| Electronic Waveform Lab, Inc. | 3 | $228 |
| Smith+Nephew | 2 | $204 |
| Zynex Medical, Inc. | 1 | $145 |
| Amgen | 6 | $106 |
| Forte Bio-pharma LLC | 1 | $74 |
| SPR Therapeutics, Inc | 1 | $68 |
| Stimwave Technologies Incorporated | 1 | $51 |
| Indivior Inc. | 2 | $42 |
| Boston Scientific | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Medline Industries LP | 1 | $25 |
| Camber Spine Technologies LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Biotronik NRO, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,102 in reported general payments places this provider in the 75th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 20 | $50,622 |
| Xtampza ErOxycodone Myristate | 76 | $36,222 |
| OxycontinOxycodone Hcl | 61 | $29,147 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 963 | $24,968 |
| LyricaPregabalin | 41 | $13,225 |
| BelbucaBuprenorphine Hcl | 14 | $9,548 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 317 | $7,506 |
| Morphine Sulfate ErMorphine Sulfate | 338 | $7,162 |
| Oxycodone Hcl | 276 | $4,708 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $4,503 |
| Buprenorphine | 17 | $3,818 |
| Pregabalin | 162 | $3,462 |
| Fentanyl | 30 | $2,386 |
| Tramadol Hcl | 229 | $2,146 |
| Gabapentin | 156 | $1,850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $17 | $50,62220 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $295 | $45,77090 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Stockbridge
- Paul WhiteStockbridge$8K
- Daniel GianoliStockbridge$8K
- Vicente GalanStockbridge$7K
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.